-FDA Approval Based on the Phase 3 AETHERA Clinical Trial Results- -AETHERA Trial Also Converts Prior Accelerated Approval to Regular Approval in Treatment of Classical Hodgkin Lymphoma Patients who...
| Monday, September 14th | 1pm ET / 10am PT | Sponsored by: Elsevier
This webinar will feature experts in drug development, regulatory processes and managed care who can shed light on the impact of escalating drug prices and provide tips on navigating these challenges. Reserve Your Spot Today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!